Larimar Therapeutics Inc. buy melinda
Start price
13.05.17
/
50%
€44.92
Target price
14.11.17
€54.12
Performance (%)
-12.05%
End price
14.11.17
€39.51
Summary
This prediction ended on 14.11.17 with a price of €39.51. The prediction for Larimar Therapeutics Inc. disappointed with a performance of -12.05%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | -6.154% | -6.154% | -19.205% | -57.565% |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% | 58.100% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% | 84.363% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% | 64.836% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% | 58.669% |
According to melinda what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Zafgen Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
(Laufzeit überschritten)
Stopped prediction by melinda for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.94
10.12.19
10.12.19
€13.00
04.11.21
04.11.21
20.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.88
07.02.19
07.02.19
€97.42
13.02.19
13.02.19
-11.83%
13.02.19
13.02.19
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€87.46
08.03.18
08.03.18
€97.42
25.06.18
25.06.18
16.58%
25.06.18
25.06.18
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€78.15
07.04.16
07.04.16
€184.01
21.07.16
21.07.16
-54.46%
21.07.16
21.07.16
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€64.73
14.03.16
14.03.16
€81.18
04.04.16
04.04.16
26.76%
04.04.16
04.04.16
Could be worthwhile Investment >10% per year


